Trial of Labor After Cesarean in a Patient with Preeclampsia and a Category II Tracing

This is a Category II tracing with recurrent late decelerations, moderate variability, and a normal baseline. Recurrent late decelerations signal uteroplacental insufficiency - the fetus is not getting enough oxygen across the placenta during contractions - and in a patient with superimposed preeclampsia and a prior cesarean scar, both fetal reserve and uterine safety are concerns.

Late decelerations are not a reason to rush to cesarean automatically, but they are a reason to act. The first steps are intrauterine resuscitation: stop or reduce oxytocin (a reasonable choice is to turn it off entirely given recurrent decelerations), reposition the mother to a left lateral position, give a 500–1,000 mL IV crystalloid bolus, and consider oxygen only if maternal hypoxemia is documented (routine oxygen is not recommended). Check maternal blood pressure - if she is hypotensive from neuraxial analgesia or antihypertensives, treat that. Assess for tachysystole; contractions every 3 minutes are not excessive, but if they become more frequent, tocolysis with terbutaline may be considered after excluding maternal contraindications.

After these measures, reassess the tracing over 20–30 minutes. If late decelerations persist despite resuscitation, or if variability decreases, or if there is a prolonged deceleration, the fetus is showing signs of intolerance and cesarean delivery should be recommended. Continuing oxytocin in the face of recurrent late decelerations is not appropriate. The patient's preference for vaginal delivery should be honored where safe, but her preference does not override evidence of fetal compromise. Document the discussion, the interventions, and the response.

Answer honestly: a trial of labor after cesarean is reasonable for many patients with one prior low-transverse incision, and most who attempt it deliver vaginally. However, this pregnancy has two added risk factors: superimposed preeclampsia with severe features (blood pressure ≥160/110 is severe, and she is at 158/102 with platelets of 96,000, elevated AST, and a persistent headache), and a Category II tracing with recurrent late decelerations. Those do not absolutely forbid vaginal delivery, but they narrow the margin for error and require continuous monitoring and immediate operating room availability.

Criteria for continuing: the fetal tracing must improve with intrauterine resuscitation; maternal blood pressure must be controlled (typically with labetalol or hydralazine, aiming below 160/110 and generally 130–150/80–100 systolic/diastolic); platelet count and liver enzymes should be rechecked; and magnesium sulfate should be started for seizure prophylaxis given severe features. Continuous fetal monitoring and one-to-one nursing are required, and the anesthesia and obstetric teams should be aware that cesarean delivery may become urgent.

Criteria for recommending cesarean: persistent late decelerations or a non-reassuring pattern after resuscitation, a prolonged deceleration, suspected scar dehiscence (loss of station, fetal bradycardia, maternal pain or hemodynamic change), or worsening maternal status such as rising blood pressure despite treatment, falling platelets, or developing HELLP syndrome. Also note that the prior cesarean was for arrest of dilation, which lowers the chance of successful vaginal delivery compared with a prior cesarean for fetal indication, and that induction or augmentation increases uterine rupture risk modestly. Present these facts, support her preference where safe, and document shared decision-making.

Priorities are maternal blood pressure control, seizure prophylaxis, coagulation assessment, and preparation for possible hemorrhage or neonatal depression.

Before incision: start magnesium sulfate (typically a 4–6 g loading dose over 20–30 minutes, then 1–2 g/h) for seizure prophylaxis; treat severe hypertension with IV labetalol or hydralazine to keep blood pressure below 160/110; confirm platelet count and coagulation studies because platelets of 96,000 raise concern for worsening thrombocytopenia and neuraxial anesthesia decisions (anesthesia will assess whether a neuraxial technique is safe or general anesthesia is needed). Type and crossmatch blood, ensure large-bore IV access, and place a urinary catheter to monitor output.

Intraoperatively: anticipate that magnesium may potentiate neuromuscular blockade and can cause hypotension; have calcium gluconate available. Anesthesia should be prepared for a difficult airway and for neonatal resuscitation. The surgeon should inspect the prior scar and be prepared for adhesions or scar dehiscence. Have uterotonics ready but be aware that some agents (for example, carboprost) are relatively contraindicated in asthma, so check the history. Monitor for hemorrhage, and have a massive transfusion protocol available.

Postoperatively: continue magnesium for 24 hours after delivery, monitor for magnesium toxicity (loss of deep tendon reflexes, respiratory depression, oliguria), continue blood pressure treatment, and monitor platelets and liver enzymes because HELLP can worsen postpartum. Encourage early ambulation and thromboprophylaxis per protocol. For the newborn, alert the resuscitation team because of prematurity risk if delivery is early and because of possible magnesium-related hypotonia.